참고문헌
- Anderson JE, Hemming AW, Chang DC, Talamini MA, Mekeel KL (2012). Surgical management trends for cholangiocarcinoma in the USA 1998-2009. J Gastrointest Surg, 16, 2225-32. https://doi.org/10.1007/s11605-012-1980-9
- Akamatsu N, Sugawara Y, Hashimoto D (2011). Surgical strategy for bile duct cancer: advances and current limitations. World J Clin Oncol, 2, 94-107. https://doi.org/10.5306/wjco.v2.i2.94
- Aslanian HR, Jamidar PA (2011). Ongoing challenges in the endoscopic management of hilar cholangiocarcinoma. Dig Dis Sci, 56, 1255-6. https://doi.org/10.1007/s10620-011-1664-4
- Friman S (2011). Cholangiocarcinoma-current treatment options. Scand J Surg, 100, 30-4.
- Hwang J, Kim YK, Park MJ, et al (2012). Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI. J Magn Reson Imaging, 36, 881-9. https://doi.org/10.1002/jmri.23728
- Kawakami H, Kondo S, Kuwatani M, et al (2011). Preoperative biliary drainage for hilar cholangiocarcinoma: which stent should be selected? J Hepatobiliary Pancreat Sci, 18, 630-5. https://doi.org/10.1007/s00534-011-0404-7
- Khan SA, Davidson BR, Goldin RD, et al (2012). Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut, 10, 1136.
- Klatskin G (1965). Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. an unusual tumor with distinctive clinical and pathological features. Am J Med, 38, 241-56. https://doi.org/10.1016/0002-9343(65)90178-6
- Kogure H, Isayama H, Kawakubo K, et al (2011). Endoscopic bilateral metallic stenting for malignant hilar obstruction using newly designed stents. J Hepatobiliary Pancreat Sci, 18, 653-65. https://doi.org/10.1007/s00534-011-0407-4
- Moon JH, Choi HJ (2011). Endoscopic double-metallic stenting for malignant biliary and duodenal obstructions. J Hepatobiliary Pancreat Sci, 18, 658-63. https://doi.org/10.1007/s00534-011-0409-2
- Nagino M, Takada T, Miyazaki M, et al (2008). Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg, 15, 25-30. https://doi.org/10.1007/s00534-007-1277-7
- Ruys AT, Haelst SV, Busch OR, et al (2012). Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg, 36, 2179-86. https://doi.org/10.1007/s00268-012-1638-5
- Sangchan A, Kongkasame W, Pugkhem A, Jenwitheesuk K, Mairiang P (2012). Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc, 76, 93-9. https://doi.org/10.1016/j.gie.2012.02.048
- Shin HR, Oh JK, Masuyer E, et al (2010). Epidemiology of cholangiocarcinoma: An update focusing on risk factors. Cancer Sci, 101, 579-85. https://doi.org/10.1111/j.1349-7006.2009.01458.x
- Van der Gaag NA, Kloek JJ, de Bakker JK, et al (2012). Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. Ann Oncol, 23, 2642-9. https://doi.org/10.1093/annonc/mds077
- Zhou Y, Zhao Y, Li B, et al (2012). Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from meta-analysis. BMC Cancer, 12, 289. https://doi.org/10.1186/1471-2407-12-289
피인용 문헌
- Analysis of Different Ways of Drainage for Obstructive Jaundice Caused by Hilar Cholangiocarcinoma vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5617
- A significant cancer burden and high mortality of intrahepatic cholangiocarcinoma in Thailand: a nationwide database study vol.17, pp.1, 2017, https://doi.org/10.1186/s12876-016-0565-6